Moron, Argentina Clinical Trials

A listing of Moron, Argentina clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

The purpose of this study is to compare the efficacy and safety of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated Staphylococcus aureus bacteremia.

Zonal General Hospital for Acute Diseases "Dr. Carlos Bocalandro"
 (6.0 away) Contact site
  • 45 views
  • 14 Jul, 2021
  • +125 other locations
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

abdominal pain
corticosteroids
crohn's disease
endoscopy
immunomodulators
Cemic Saavedra
 (9.6 away) Contact site
  • 865 views
  • 09 Mar, 2021
  • +420 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

antibiotics
severe chronic obstructive pulmonary disease
corticosteroids
bronchodilator
eosinophil count
Research Site
 (6.0 away) Contact site
  • 838 views
  • 10 Jul, 2021
  • +426 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

crohn's disease
remission
Cemic Saavedra
 (9.6 away) Contact site
  • 1035 views
  • 22 Feb, 2021
  • +807 other locations
Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy

etoposide
limited stage small cell lung cancer
cancer chemotherapy
prophylactic cranial irradiation
chemoradiotherapy
Research Site
 (4.4 away) Contact site
  • 268 views
  • 01 Aug, 2021
  • +246 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

arterial disease
stroke
percutaneous coronary intervention
myocardial infarction
diabetes
0320033 - Corporacion Medica de San Martin
 (5.4 away) Contact site
  • 1118 views
  • 01 Aug, 2021
  • +3430 other locations
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

Study MO39874 is an open-label, phase IIIb, single arm, multicenter study conducted in participants with unresectable locally advanced or metastatic PD-L1-positive Triple-Negative Breast Cancer (TNBC) who have not received chemotherapy for their unresectable locally advanced or metastatic disease.

metastasis
triple-negative breast cancer
paclitaxel
serum pregnancy test
HER2
Instituto de Investigaciones Metabolicas (Idim)
 (8.6 away) Contact site
  • 147 views
  • 01 Aug, 2021
  • +162 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

crohn's disease
ustekinumab
Instituto Medico Elsa Perez SRL (IMEP)
 (4.4 away) Contact site
  • 646 views
  • 25 Jul, 2021
  • +991 other locations
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

stroke
myocardial infarction
diabetes
arterial disease
infarct
Dim Clinica Privada
 (2.9 away) Contact site
  • 536 views
  • 04 Jul, 2021
  • +1332 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
body mass index
hemoglobin a1c
DIM Clinica Privada
 (3.1 away) Contact site
  • 593 views
  • 29 Jul, 2021
  • +888 other locations